Umbilical
Cords Could Repair Brains
By DANIEL Q. HANEY The Associated Press February 19, 20001
SAN FRANCISCO (AP) - Cells taken from umbilical cords after birth may offer a vast source of material - free of the ethical concerns of fetal tissue - for repairing brains damaged by strokes and other ills, researchers said Sunday.
In animal experiments, at least,
these cells appear to greatly speed recovery after strokes. They work with a
simple infusion into the blood stream without the need for direct implantation
into the brain.
Although many details need to be
worked out, Dr. Paul R. Sanberg of the University of South Florida said
he hopes to try the approach on stroke victims within the next year or two.
Sanberg described the research
at a meeting in San Francisco of the American Association for the Advancement of
Science. It was financed by the state of Florida and Cryo-Cell International
Inc. of Clearwater, Fla. Many
experts believe that primitive tissue called stem cells will someday be
routinely used to make human spare parts. They might replace tissue damaged by
many different diseases, especially such brain ailments as strokes and
Alzheimer's disease. These generic cells can be nudged to develop into all sorts
of specialized tissue to repopulate every part of the body from head to toe. One
source of stem cells is aborted fetuses or fertility clinics' discarded embryos.
However, this is especially contentious since anti-abortion groups oppose fetal
and embryonic stem cell research, and federally funded scientists cannot use
stem cells from these sources.
Sanberg said his research
suggests that umbilical cords could be an excellent source of stem cells without
the ethical headaches of fetal tissue. He noted that 4 million babies are born
in the United States each year, and 99 percent of their cord blood is tossed
away.
He said one or two cords could
probably provide enough stem cells to treat one human stroke victim, if the
current approach proves useful. The cells could be frozen for use when needed.
In experiments so far, his team removed stem cells from cords and then used
retinoic acid and growth hormones to transform them into immature nerve cells.
They then injected 3 million of these cells into the bloodstreams of rats that
had suffered strokes.
In experiments on about 60 rats,
the team found that after one month, those given the cells had recovered about
80 percent from their strokes, compared with about 20 percent in untreated rats.
Sanberg said the treatment works
best when given within 24 hours of a stroke but still helps up to a week later.
Just how the new cells rewire the damaged parts of the brain is unclear,
although the cells can take on the form of distinctly different types of brain
tissue, and they also appear to prompt damaged cells to repair themselves.
"They are attracted to the
stroke part of the brain more than the normal brain,'' he said. "Some
signal is being sent that attracts them.''
Sanberg cautioned that many
questions remain, such as whether the cells should be given in several doses,
how many should be infused, and whether the treatment will require suppression
of the immune system, since the body might otherwise reject the foreign tissue.
"This is very exciting,'' said Dr. Sandra Chapman of the University of Texas at Dallas. "The potential of this will be an exponential improvement in our chance of treating all sorts of brain disorders.''
American Association for the Advancement of Science: http://www.aaas.org/